AbbVie Inc (BUE:ABBV)
ARS 21100 275 (1.32%) Market Cap: 326.28 Til Enterprise Value: 391.76 Til PE Ratio: 63.33 PB Ratio: 53.42 GF Score: 74/100

Abbvie Inc at Sanford C Bernstein Strategic Decisions Conference (Virtual) Transcript

Jun 02, 2021 / 07:30PM GMT
Aaron Gal
Sanford C. Bernstein & Co., LLC., Research Division - Senior Research Analyst

Hi, everybody, and thank you for joining us today. A fair presentation today. We are going to -- we are very lucky to have AbbVie with us, Dr. Michael Severino, the Vice Chairman and President of the organization; and Rob Michael, the SVP and CFO.

So thank you, gentlemen, both for being with us today. We really appreciate it.

Questions & Answers

Aaron Gal
Sanford C. Bernstein & Co., LLC., Research Division - Senior Research Analyst

Let's start a little bit bigger -- with a couple of bigger questions. So just in general, my impression is that AbbVie is considered to be a very good commercial organization. And I was wondering kind of like what tools do you guys have that other companies not have. What have you honed in, in terms of capabilities that other companies are still struggling with?

Michael E. Severino
AbbVie Inc. - Vice Chairman & President

Well, thanks, Ronny. It's a pleasure to be here

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot